Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 3142926, 7 pages
https://doi.org/10.1155/2017/3142926
Research Article

Preoperative Gamma-Glutamyltransferase Is Associated with Cancer-Specific Survival and Recurrence-Free Survival of Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus

Department of Urology, Peking University First Hospital and Institute of Urology, Peking University, National Urological Cancer Center, 8 Xishiku Street, Xicheng District, Beijing 100034, China

Correspondence should be addressed to Qian Zhang and Jie Jin

Received 21 September 2016; Revised 23 November 2016; Accepted 20 December 2016; Published 11 January 2017

Academic Editor: Antonello Merlino

Copyright © 2017 Cheng Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics,” CA Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7–30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. N. K. Bissada, H. H. Yakout, A. Babanouri et al., “Long-term experience with management of renal cell carcinoma involving the inferior vena cava,” Urology, vol. 61, no. 1, pp. 89–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Lardas, F. Stewart, D. Scrimgeour et al., “Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus,” European Urology, vol. 70, no. 2, pp. 265–280, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Klatte, A. J. Pantuck, S. B. Riggs et al., “Prognostic factors for renal cell carcinoma with tumor thrombus extension,” Journal of Urology, vol. 178, no. 4, pp. 1189–1195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. H. Kim, D. You, I. G. Jeong et al., “Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus,” BJU International, vol. 110, no. 11, pp. E673–E678, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Parra, S. J. Drouin, V. Hupertan, E. Comperat, M. O. Bitker, and M. Rouprêt, “Oncological outcomes in patients undergoing radical nephrectomy and vena cava thrombectomy for renal cell carcinoma with venous extension: a single-centre experience,” European Journal of Surgical Oncology, vol. 37, no. 5, pp. 422–428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Nakayama, K. Saito, Y. Fujii et al., “Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy,” Japanese Journal of Clinical Oncology, vol. 44, no. 8, pp. 756–761, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Wagner, J.-J. Patard, A. Méjean et al., “Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma,” European Urology, vol. 55, no. 2, pp. 452–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Tilki, H. G. Nguyen, M. A. Dall'Era et al., “Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus,” European Urology, vol. 66, no. 3, pp. 577–583, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Q. Haddad, C. G. Wood, E. J. Abel et al., “Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort,” Journal of Urology, vol. 192, no. 4, pp. 1050–1056, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. Hanigan, B. C. Gallagher, D. M. Townsend, and V. Gabarra, “γ-Glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo,” Carcinogenesis, vol. 20, no. 4, pp. 553–559, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-S. Xu, Y. Wan, S.-D. Song et al., “Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis,” World Journal of Gastroenterology, vol. 20, no. 31, pp. 10944–10952, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Staudigl, N. Concin, C. Grimm et al., “Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer,” PLOS ONE, vol. 10, no. 4, Article ID e0125317, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Yang, S. Zhang, H. Yang et al., “Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma,” Diseases of the Esophagus, vol. 28, no. 5, pp. 496–504, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Grimm, G. Hofstetter, S. Aust et al., “Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer,” British Journal of Cancer, vol. 109, no. 3, pp. 610–614, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. L. Hofbauer, K. I. Stangl, M. De Martino et al., “Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma,” British Journal of Cancer, vol. 111, no. 8, pp. 1526–1531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Dalpiaz, M. Pichler, E. Mrsic et al., “Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma,” Journal of Clinical Pathology, vol. 68, no. 7, pp. 547–551, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Neves and H. Zincke, “Surgical treatment of renal cancer with vena cava extension,” British Journal of Urology, vol. 59, no. 5, pp. 390–395, 1987. View at Publisher · View at Google Scholar · View at Scopus
  19. D. S. Sandock, A. D. Seftel, and M. I. Resnick, “The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma,” The Journal of Urology, vol. 157, no. 3, pp. 798–799, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Strasak, G. Goebel, H. Concin et al., “Prospective study of the association of serum γ-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer,” Cancer Research, vol. 70, no. 9, pp. 3586–3593, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. H. Hanigan and H. F. Frierson, “Immunohistochemical detection of γ-glutamyl transpeptidase in normal human tissue,” Journal of Histochemistry and Cytochemistry, vol. 44, no. 10, pp. 1101–1108, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Fischer and J. E. Scherberich, “Hybridomas reveal shared immunodominant epitopes of γ-glutamyltransferase isoforms from human kidney and renal cell carcinoma,” Tumor Biology, vol. 17, no. 6, pp. 369–377, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Franzini, A. Corti, E. Lorenzini et al., “Modulation of cell growth and cisplatin sensitivity by membrane γ-glutamyltransferase in melanoma cells,” European Journal of Cancer, vol. 42, no. 15, pp. 2623–2630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Corti, M. Franzini, A. Paolicchi, and A. Pompella, “Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting,” Anticancer Research, vol. 30, no. 4, pp. 1169–1181, 2010. View at Google Scholar · View at Scopus
  25. S. Daubeuf, M. J. Accaoui, I. Pettersen, N. E. Huseby, A. Visvikis, and M. M. Galteau, “Differential regulation of γ-glutamyltransferase mRNAs in four human tumour cell lines,” Biochimica et Biophysica Acta - General Subjects, vol. 1568, no. 1, pp. 67–73, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Bouman, J. Sancéau, D. Rouillard, and B. Bauvois, “γ-Glutamyl transpeptidase expression in Ewing's sarcoma cells: up-regulation by interferons,” Biochemical Journal, vol. 364, no. 3, pp. 719–724, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. C. Cho, J. K. Kim, K. C. Moon, H. H. Kim, and C. Kwak, “Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system,” International Braz J Urol, vol. 39, no. 3, pp. 353–363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. E. J. Abel, V. Margulis, T. M. Bauman et al., “Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis,” BJU International, vol. 117, no. 6, pp. E87–E94, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Q. Haddad, B. C. Leibovich, E. J. Abel et al., “Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus,” Urologic Oncology: Seminars and Original Investigations, vol. 33, no. 9, pp. 388.e1–388.e9, 2015. View at Publisher · View at Google Scholar · View at Scopus